W F Carman

Author PubWeight™ 72.73‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis 1997 3.39
2 Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region. Hepatology 2001 2.30
3 Incidence and recall of influenza in a cohort of Glasgow healthcare workers during the 1993-4 epidemic: results of serum testing and questionnaire. BMJ 1996 2.01
4 Real-time RT-PCR detection of 12 respiratory viral infections in four triplex reactions. J Clin Virol 2005 1.86
5 Treatment of chronic hepatitis B virus infection: an Asia-Pacific perspective. J Gastroenterol Hepatol 1999 1.54
6 Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients. J Clin Virol 2003 1.53
7 Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: a viral dynamics study. Hepatology 2000 1.50
8 Polymerase chain reaction for diagnosis of genital herpes in a genitourinary medicine clinic. Sex Transm Infect 2002 1.49
9 BK viremia surveillance after kidney transplant: single-center experience during a change from cyclosporine-to lower-dose tacrolimus-based primary immunosuppression regimen. Transpl Infect Dis 2010 1.40
10 Determinants of universal adolescent hepatitis B vaccine uptake. Arch Dis Child 2004 1.37
11 Longitudinal study of genital infection by herpes simplex virus type 1 in Western Scotland over 15 years. BMJ 2002 1.37
12 Occurrence of haemagglutinin mutation D222G in pandemic influenza A(H1N1) infected patients in the West of Scotland, United Kingdom, 2009-10. Euro Surveill 2010 1.34
13 Costs of running a universal adolescent hepatitis B vaccination programme. Vaccine 2005 1.21
14 Practical experience of high throughput real time PCR in the routine diagnostic virology setting. J Clin Virol 2006 1.21
15 Influenza diagnosis: from dark isolation into the molecular light. West of Scotland Respiratory Virus Study Group. J Infect 1999 1.18
16 Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays. Hepatology 2000 1.16
17 Prevalence of chronic viral hepatitis in people of south Asian ethnicity living in England: the prevalence cannot necessarily be predicted from the prevalence in the country of origin. J Viral Hepat 2009 1.14
18 2009 pandemic influenza A(H1N1) virus in Scotland: geographically variable immunity in Spring 2010, following the winter outbreak. Euro Surveill 2010 1.13
19 HBV core sequence: definition of genotype-specific variability and correlation with geographical origin. J Viral Hepat 2004 1.11
20 Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries. Vaccine 2004 1.10
21 Nosocomial transmission of influenza. Occup Med (Lond) 2002 1.07
22 Use of PCR in resolving diagnostic difficulties potentially caused by genetic variation of hepatitis B virus. J Clin Pathol 1998 1.05
23 T1762/A1764 variants of the basal core promoter of hepatitis B virus; serological and clinical correlations in Chinese patients. Liver 1999 1.04
24 The clinical significance of molecular variation within the hepatitis B virus genome. Hepatology 1992 1.02
25 Norwalk like virus by light cycler PCR. J Clin Virol 2002 0.99
26 Hepatitis B virus precore/core variation and interferon therapy. Hepatology 1995 0.99
27 Serological response to influenza vaccination and nutritional and functional status of patients in geriatric medical long-term care. Age Ageing 1999 0.98
28 Using multiplex real time PCR in order to streamline a routine diagnostic service. J Clin Virol 2008 0.98
29 A multi-centre pilot proficiency programme to assess the quality of molecular detection of respiratory viruses. J Clin Virol 2005 0.97
30 Development of a multiplex real-time RT-PCR that allows universal detection of influenza A viruses and simultaneous typing of influenza A/H1N1/2009 virus. J Virol Methods 2009 0.96
31 Genotypic analysis of sequential genital herpes simplex virus type 1 (HSV-1) isolates of patients with recurrent HSV-1 associated genital herpes. J Med Virol 2004 0.94
32 The predicted pattern of emergence of vaccine-resistant hepatitis B: a cause for concern? Vaccine 1999 0.94
33 Importance of PCR in the diagnosis and understanding of rotavirus illness in the community. Commun Dis Public Health 2003 0.93
34 HGV: the identification, biology and prevalence of an orphan virus. Liver 1998 0.93
35 Current status of HBV vaccine escape variants--a mathematical model of their epidemiology. J Viral Hepat 1998 0.93
36 The effect of introduction of universal childhood hepatitis B immunization in South Africa on the prevalence of serologically negative hepatitis B virus infection and the selection of immune escape variants. Vaccine 2001 0.90
37 Population exposure to a novel influenza A virus over three waves of infection. J Clin Virol 2011 0.89
38 Comparison of real-time PCR and EIA for the detection of outbreaks of acute gastroenteritis caused by norovirus. Commun Dis Public Health 2003 0.89
39 Predictions of the emergence of vaccine-resistant hepatitis B in The Gambia using a mathematical model. Epidemiol Infect 2000 0.86
40 Clinical implications of hepatitis B virus envelope protein variation. Int J Clin Lab Res 1994 0.86
41 Universal hepatitis B vaccination of UK adolescents: a feasibility and acceptability study. Commun Dis Public Health 2002 0.86
42 Emergence of a new norovirus variant in Scotland in 2006. J Clin Microbiol 2007 0.85
43 Comparison of two real-time PCR methods for diagnosis of norovirus infection in outbreak and community settings. J Clin Microbiol 2005 0.84
44 Envelope and precore/core variants of hepatitis B virus. Gastroenterol Clin North Am 1994 0.83
45 Molecular characterization of envelope antigenic variants of hepatitis B virus from Spain. J Infect Dis 1994 0.83
46 Hepatitis B virus: origin and evolution. J Viral Hepat 2009 0.83
47 The real-time detection of sapovirus. J Clin Virol 2006 0.83
48 An efficient extraction method from blood clots for studies requiring both host and viral DNA. J Viral Hepat 2000 0.83
49 Influenza A(H1N1)2009 antibody seroprevalence in Scotland following the 2010/11 influenza season. Euro Surveill 2011 0.82
50 Selection of hepatitis B surface "escape" mutants during passive immune prophylaxis following liver transplantation: potential impact of genetic changes on polymerase protein function. Gut 1999 0.82
51 The hepatitis B virus. Baillieres Clin Gastroenterol 1990 0.82
52 Transmission of hepatitis B virus from a vaccinated healthcare worker. J Hosp Infect 2007 0.82
53 Blastomyces dermatitidis infections in the RSA. S Afr Med J 1989 0.81
54 First rotavirus, now astrovirus: the evolving benefits of RT-PCR. Commun Dis Public Health 2003 0.81
55 Failed adoptive immunity transfer: reactivation or reinfection? J Viral Hepat 1999 0.80
56 Effect of cyclosporin-A in woodchucks with chronic hepatitis delta virus infection. J Med Virol 1992 0.80
57 Simultaneous detection and quantitation of cytomegalovirus, Epstein-Barr virus, and adenovirus by use of real-time PCR and pooled standards. J Clin Microbiol 2009 0.79
58 Life-threatening human metapneumovirus infections in West of Scotland. J Clin Virol 2007 0.78
59 The host immune response may be responsible for selection of envelope and precore/core variants of HBV. Prog Liver Dis 1992 0.78
60 Transmission of a homogenous hepatitis B virus population of A1896-containing strains leading to mild resolving acute hepatitis and seroconversion to hepatitis B e antigen antibodies in an adult. Hepatology 1997 0.77
61 Contamination with PCR detectable virus in a virus isolation quality assurance panel. J Virol Methods 2006 0.77
62 Further characterization of 2 types of precore variant hepatitis B virus isolates from Hong Kong. J Infect Dis 1995 0.77
63 The host immune response may be responsible for selection of envelope and precore/core variants of HBV. J Hepatol 1991 0.76
64 Hepatitis B and health care workers. Lancet 1997 0.76
65 Core variability does not affect response to interferon alpha in HBeAg negative chronic hepatitis B. J Hepatol 1998 0.76
66 Age related prevalence of hepatitis G virus in South Africans. J Clin Pathol 1999 0.76
67 Influenza in old age. Age Ageing 2001 0.76
68 Detection of hepatitis B virus DNA sequences in liver in HBsAg seronegative patients with liver disease with and without anti-HBc antibodies. Q J Med 1991 0.75
69 Hospital transmission of hepatitis B virus in the absence of exposure prone procedures. Epidemiol Infect 2006 0.75
70 Recombinant vaccinia viruses expressing hepatitis A virus structural polypeptides: detection of an anti-VP0 response in convalescent-phase sera. Clin Diagn Lab Immunol 1995 0.75
71 Microneutralisation assays for the detection of 2009 pandemic influenza A(H1N1) antibodies: a comparative test of serum and plasma. J Clin Virol 2010 0.75
72 The effectiveness of national influenza vaccination policies for at-risk populations over 5 seasons in a Scottish general practice. Vaccine 2008 0.75
73 Replication of hepatitis B and delta viruses: appearance of viral mutants. Semin Liver Dis 1991 0.75
74 An unidentified hepatitis B virus carrier on a haemodialysis unit: management and outcome. J Hosp Infect 2001 0.75
75 Antiviral prophylaxis and treatment (excluding HIV therapy). J Clin Virol 2002 0.75
76 Hepatitis viruses. Baillieres Clin Gastroenterol 1990 0.75
77 Avoiding errors in the molecular epidemiological analysis of hepatitis B virus transmission incidents. J Clin Virol 2005 0.75